I am notoriously a glass half empty sort of bloke,
but to me this is excellent news for the long
term. A much larger trial allowing for much
more weighty evidence for applications to
TGA and FDA.
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.005(1.22%) |
Mkt cap ! $160.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 40.0¢ | $87.37K | 216.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 13980 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 3900 | 2 |
View Market Depth
| Last trade - 11.45am 18/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |